本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Bone Biologics Corp

3.49
-0.1300-3.59%
盘后3.46-0.0300-0.86%16:52 EDT
成交量:13.11万
成交额:46.60万
市值:560.25万
市盈率:-0.17
高:3.65
开:3.63
低:3.49
收:3.62
数据加载中...
2022/10/04

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/09/23

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2022/08/24

重要事件披露

8-K - Current report
2022/08/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/07/07

SEC问询函

CORRESP [Cover] - Correspondence
2022/06/09

重要事件披露

8-K - Current report
2022/05/23

重要事件披露

8-K - Current report
2022/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/15

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/08

重要事件披露

8-K - Current report
2021/12/22

重要事件披露

8-K - Current report
2021/10/21

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/10/21

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/10/19

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/08

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/08

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/07

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/06

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/08/30

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/08/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]